When GLP-1s arrived, social media feeds began to look different as body positivity influencers started to drop off
Rotating injection sites can help prevent these reactions
What we do know: About 15 percent of GLP-1 users have never been diagnosed with one of the predominant conditions the drug is intended to treat (specifically, obesity or being overweight, diabetes, and heart disease), and about one in six Americans who have used a GLP-1 ordered it online, and one in ten got it from a med spa, according to a recent national poll from KFF
A New England Journal of Medicine study published in 2021 found participants receiving GLP-1 drugs were more likely to show significant, sustained weight loss compared with those getting a placebo
Theres a case to be made that this begins to resemble sham litigation as a form of anti-competitive conduct
Treatment Administration BPC 157 is typically administered via injection under medical guidance